STAT

AUGUST 29, 2023

Climate change is an existential problem for human health. As climate change intensifies, the frequency and severity of extreme weather events such as heatwaves, cold fronts, and floods will increase. Undoubtedly, this will result in devastating effects for human health and wellbeing, contributing to increased susceptibility to infectious diseases, an already growing mental health crisis, and, most directly, heat-related mortality.

266

266

PharmaVoice

AUGUST 29, 2023

The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.

265

265

STAT

AUGUST 29, 2023

Advance directives were born in the Senate. Now they can help preserve the dignity of its aging members. In Cruzan v. Director, Missouri Department of Health , the parents of Nancy Cruzan, a young woman who had been left in a permanent vegetative state after a car accident, wanted the right to remove her life support. In 1990, the Supreme Court ruled in favor of her parents, affirming the constitutional right to refuse life-sustaining treatment.

255

255

PharmaVoice

AUGUST 29, 2023

Work-life balance is one major common denominator among the top-ranked pharma employers on Glassdoor.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

AUGUST 29, 2023

Insulet filed a lawsuit this month against its rival EOFlow, accusing it of stealing trade secrets in a case that could shake up the diabetes technology market and throw a wrench in Medtronic’s planned $738 million acquisition of EOFlow. Insulet alleges that the South Korea-based EOFlow copied the design for its only product, a patch pump, called the Omnipod that delivers insulin to people with diabetes.

Diabetes 224

Diabetes 224

BioPharma Dive

AUGUST 29, 2023

A broadened clearance for Reblozyl in myelodysplastic syndromes should help Bristol Myers offset the looming loss of revenue from top-selling medicines set to soon lose market exclusivity.

112

112

BioPharma Dive

AUGUST 29, 2023

The list includes the top-selling blood thinners Eliquis and Xarelto, as well as the arthritis drug Enbrel and heart failure medicine Entresto.

115

115

Pharma Times

AUGUST 29, 2023

The ODD will offer clinical development and commercialisation benefits that will strengthen the drug programme - News - PharmaTimes

105

105

Express Pharma

AUGUST 29, 2023

analytica Anacon India, India Lab Expo and Pharma Pro&Pack Expo will be held from 14-16 September 2023 at HITEX Exhibition Center, Hyderabad After the successful conclusion in Mumbai, analytica Anacon India and India Lab Expo 2023 is all set to take place along with Pharma Pro&Pack Expo in the pharma hub of India, Hyderabad. This is the largest-ever edition of the event in Hyderabad and with this year’s theme, ‘Epicentre of Progress’, the event showcases solutions for the entire value ch

Research Laboratories 94

Research Laboratories Packaging 94

PioneerRx

AUGUST 29, 2023

Pharmacy work is an ongoing journey. Whether we’re talking about your fill queue, vaccine quotas, or your patient’s health journey, the work of an independent.

Vaccines 98

Vaccines 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

AUGUST 29, 2023

Strides Pharma Science announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte, Singapore, has received approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), CellCept for Oral Suspension, 200 mg/mL of Roche Palo Alto.

92

92

The Pharmacist

AUGUST 29, 2023

Community pharmacies in England delivered a total of 149,865 blood pressure checks to over 40s in May 2023 – over double the 58,345 delivered in the same month last year. This comes as the NHS announces a major drive to tackle cardiovascular health, with local projects offering blood pressure checks in non-healthcare settings such as […] The post Community pharmacy blood pressure checks more than double in a year appeared first on The Pharmacist.

Community Pharmacies 91

Community Pharmacies 91

European Pharmaceutical Review

AUGUST 29, 2023

Experts at the European Medicines Agency (EMA) have provided a regulatory perspective on risk factors and mitigation strategies for nitrosamine impurities in human drug products. The paper highlighted an Article 31 referral into medicine safety which began in the EU in September 2019. Above acceptable levels of N-nitrosodimethylamine (NDMA) had been detected in ranitidine tablets and thus investigated.

90

90

The Pharmacist

AUGUST 29, 2023

From 1 September community pharmacies will be required to use an approved clinical IT system to record clinical details and payment claims for the NHS hypertension service. And all claims for August must be submitted manually through MYS by Tuesday 5 September. The NHS Blood Pressure Check Service began in October 2021, with pharmacy technicians […] The post Hypertension service must use approved IT system from this week appeared first on The Pharmacist.

Pharmacy Technician 90

Pharmacy Technician Community Pharmacies 90

Express Pharma

AUGUST 29, 2023

The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for medicine) Mankind Pharma has introduced 120 DMF (Drug Master File) Quality Medicines in the Indian market. This initiative aims to ensure universal access to medicines of international calibre. India stands as a global leader in offering generic medicines that adhere to the stringent DMF quality standards set for Active Pharmaceutical Ingredients (APIs).

Generic Medicine 88

Generic Medicine Packaging 88

European Pharmaceutical Review

AUGUST 29, 2023

The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised the first subcutaneous formulation of an anti-PD-(L)1 cancer immunotherapy to be made available to patients in Great Britain. Administration of Roche’s Tecentriq ® SC (atezolizumab) takes approximately seven minutes. This is compared to 30-60 minutes via intravenous (IV) administration.

Immunity 86

Immunity Immunization 86

Express Pharma

AUGUST 29, 2023

One standout aspect of DART is its seamless integration into existing workflows, enhancing end-user engagement The FDA Modernisation Act 2.0 marks a pivotal moment in reshaping the global pharma and biopharmaceutical industry. Additionally, the Indian DCGI has granted authorization for the use of alternative methods to animal testing, such as cell-based assays and computer models.

Biosimilars 86

Biosimilars 86

PharmaTech

AUGUST 29, 2023

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

98

98

Pharma Times

AUGUST 29, 2023

ImmunoGen is expected to receive an upfront payment from Takeda plus additional payment - News - PharmaTimes

97

97

The Pharmacist

AUGUST 29, 2023

The Pharmacists’ Defence Association (PDA) ‘routinely’ receives reports about managers overruling the clinical judgement of registered pharmacists, potentially impacting patient safety, it has said. And it raised ‘significant concerns’ about the power of non-clinical managers in community pharmacies, especially those operated by large private companies.

Community Pharmacies 71

Community Pharmacies Clinic Management Pharmacy Management 71

cureatr

AUGUST 29, 2023

The Centers for Medicare & Medicaid Services (CMS) released its 2024 Medicare Advantage and Part D Final Rule in April. Notably absent from all 724 pages of the final rule? Proposed changes to eligibility requirements for the Part D Medication Therapy Management (MTM) Program.

Medication Therapy Management (MTM) 67

Medication Therapy Management (MTM) 67

EMCrit Project

AUGUST 29, 2023

A deeper dive on accidental hypothermia in anticipation of my much awaited winter EMCrit Project by Scott Weingart, MD FCCM.

82

82

The Guardian - Pharmaceutical Industry

AUGUST 29, 2023

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional The Biden administration has selected 10 drugs for the first round of price negotiations between Medicare and pharmaceutical companies in an effort to lower costs for seniors, it announced on Tuesday. The list of prescription drugs includes blood thinners and treatments for diabetes, as well as drugs used to treat kidney disease, heart failure and arthritis.

Diabetes 71

Diabetes Pharmaceutical Companies Pharmaceutical Companies 71

pharmaphorum

AUGUST 29, 2023

BlueRock clears key hurdle in Parkinson's stem cell trial Phil.

104

104

Drug Channels

AUGUST 29, 2023

We’re wrapping up one of newsiest summers in recent memory. Time to pack away your bathing suit, send the kids back to school, and cherish these curated curiosities that I combed from the Jersey Shore: Fresh evidence of patients’ copay maximizer pain How payers pay more to hospitals than to physician offices Surprise? Rationing care via bureaucracy saves money Plus, the June 2023 update to my all-time favorite chart.

Hospitals 86

Hospitals Physician Offices 86

pharmaphorum

AUGUST 29, 2023

FTC hold raises hope of Amgen/Horizon deal progress Phil.

103

103

World Pharma News

AUGUST 29, 2023

Findings from the Garvan Institute of Medical Research reveal a new Australian drug that targets scar-like 'fibrotic' tissue within tumours shows promise for treating pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer with a five-year survival rate of less than 10%. The research in mouse models showed that when given in combination with chemotherapy, the drug PXS-5505 increased survival time by more than 35%, compared to chemotherapy treatment alone.

Chemotherapy 62

Chemotherapy 62

pharmaphorum

AUGUST 29, 2023

BMS grabs key approval for Reblozyl in MDS Phil.

105

105

Pharmafile

AUGUST 29, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for full approval of Balversa (erdafitinib) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC). The drug received Breakthrough Therapy Designation from the […] The post Janssen submits sNDA to FDA for full approval of Balversa appeared first on Pharmafile.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 29, 2023

An overview of AI in pharma – Part 2 Mike.

106

106

Pharmafile

AUGUST 29, 2023

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company for the development and commercialisation of Elahere (mirvetuximab soravtansine-gynx) in Japan. Under the terms of the agreement, ImmunoGen is expected to receive a one-time, upfront payment as well as an additional payment upon conversion of the US Food and Drug […] The post Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan appeared first

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 29, 2023

First 10 drugs subject to Medicare negotiations named Phil.

94

94

Pharmafile

AUGUST 29, 2023

Faron Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its bexmarilimab for acute myeloid leukemia (AML). The ODD will offer clinical development and commercialisation benefits that will ultimately strengthen the drug programme. The drug is currently in a phase 1 study where it is being […] The post FDA gives Orphan Drug Designation to Faron Pharmaceuticals’ Bexmarilimab appeared first on Pharmafile.

52

52

pharmaphorum

AUGUST 29, 2023

GB first to approve Roche's subcutaneous Tecentriq Phil.

92

92

Compounding Pharmacy of America

AUGUST 29, 2023

Our new line of STAAR LABS supplements converge at the crossroads of modern science and traditional well-being practices. The post Introducing Our New Line of STAAR LABS Supplements appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52